Does IMATINIB Cause Neoplasm? 164 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 164 reports of Neoplasm have been filed in association with IMATINIB (Imatinib). This represents 0.4% of all adverse event reports for IMATINIB.
164
Reports of Neoplasm with IMATINIB
0.4%
of all IMATINIB reports
26
Deaths
34
Hospitalizations
How Dangerous Is Neoplasm From IMATINIB?
Of the 164 reports, 26 (15.9%) resulted in death, 34 (20.7%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 164 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Neoplasm?
ADALIMUMAB (513)
OCTREOTIDE (366)
RITUXIMAB (323)
LENALIDOMIDE (242)
CYCLOPHOSPHAMIDE (221)
BEVACIZUMAB (207)
INFLIXIMAB (201)
ETANERCEPT (194)
RIBOCICLIB (194)
METHOTREXATE (165)
Which IMATINIB Alternatives Have Lower Neoplasm Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL